JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental material
Right arrow Other Versions of this Article:
JCM.02231-07v1
46/4/1259    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gibson, A. L.
Right arrow Articles by Ho, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gibson, A. L.
Right arrow Articles by Ho, J. L.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, April 2008, p. 1259-1267, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.02231-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Application of Sensitive and Specific Molecular Methods To Uncover Global Dissemination of the Major RDRio Sublineage of the Latin American-Mediterranean Mycobacterium tuberculosis Spoligotype Family{triangledown} ,{ddagger}

Andrea L. Gibson,1,{dagger} Richard C. Huard,1,2,{dagger} Nicolaas C. Gey van Pittius,3 Luiz Claudio Oliveira Lazzarini,1,4 Jeffrey Driscoll,5 Natalia Kurepina,6 Thierry Zozio,7 Christophe Sola,7,8 Silvana Miranda Spindola,9 Afrânio L. Kritski,4 Daniel Fitzgerald,1,10 Kristin Kremer,11 Helmi Mardassi,12 Poonam Chitale,1 Jessica Brinkworth,1,13 Dario Garcia de Viedma,14,15 Brigitte Gicquel,8 Jean W. Pape,10 Dick van Soolingen,11 Barry N. Kreiswirth,6 Robin M. Warren,3 Paul D. van Helden,3 Nalin Rastogi,7 Philip N. Suffys,16 Jose Lapa e Silva,4 and John L. Ho1*

Department of Medicine, Division of International Medicine and Infectious Diseases, Weill Medical College of Cornell University, New York, New York,1 Clinical Microbiology Service and the Department of Pathology, Columbia University Medical Center, New York-Presbyterian Hospital, New York, New York,2 DST/NRF Centre of Excellence in Biomedical Tuberculosis Research, US/MRC Centre for Molecular and Cellular Biology, Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa,3 Institute of Thoracic Diseases, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil,4 Wadsworth Center, New York State Department of Health, Albany, New York,5 Public Health Research Institute, Newark, New Jersey,6 Unité de la Tuberculose et des Mycobactéries, Institut Pasteur de Guadeloupe, Guadeloupe,7 Unité de Génétique Mycobactérienne, Institut Pasteur, Paris, France,8 Departamento de Clínica Médica/Pneumologia, Faculdade de Medicina, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil,9 GHESKIO Centers, Port-au-Prince, Haiti,10 National Institute of Public Health and the Environment, Bilthoven, The Netherlands,11 Laboratoire des Mycobactéries, Institut Pasteur de Tunis, Tunisia,12 Department of Anthropology, Graduate School and University Center, City University of New York/New York Consortium in Evolutionary Primatology, New York, New York,13 Servicio de Microbiología Clínica y Enfermedades Infecciosas, Hospital Gregorio Marañón, Madrid, Spain,14 CIBER Enfermedades Respiratorias, Madrid, Spain,15 Laboratory of Molecular Biology Applied to Mycobacteria, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil,16

Received 19 November 2007/ Returned for modification 27 December 2007/ Accepted 9 January 2008

The Latin American-Mediterranean (LAM) family of Mycobacterium tuberculosis is believed to be the cause of ~15% of tuberculosis cases worldwide. Previously, we defined a prevalent sublineage of the LAM family in Brazil by a single characteristic genomic deletion designated RDRio. Using the Brazilian strains, we pinpoint an Ag85C103 single nucleotide polymorphism (SNP) (screened by restriction fragment length polymorphism [RFLP] analysis) that correctly identified all LAM family strains. Importantly, all RDRio strains concomitantly possessed the RD174 deletion. These genetic signatures, along with a newly developed multiplex PCR for rapid differentiation between "wild-type" and RDRio strains, were then used to analyze an international collection of M. tuberculosis strains. RDRio M. tuberculosis was identified from four continents involving 11 countries. Phylogenetic analysis of the IS6110-RFLP patterns from representative RDRio and LAM strains from Brazil, along with all representative clusters from a South African database, confirmed their genetic relatedness and transcontinental transmission. The Ag85C103 SNP RFLP, as compared to results obtained using a PCR method targeting a LAM-restricted IS6110 element, correctly identified 99.8% of LAM spoligotype strains. Together, these tests were more accurate than spoligotyping at categorizing strains with indefinable spoligotypes and segregated true LAM strains from those with convergent spoligotypes. The fact that RDRio strains were identified worldwide highlights the importance of this LAM family sublineage and suggests that this strain is a global threat that should be specifically targeted by public health resources. Our provision of simple and robust molecular methods will assist the evaluation of the LAM family and the RDRio sublineage.


* Corresponding author. Mailing address: Cornell University, Joan and Sanford I. Weill Medical College, Department of Medicine, Division of International Medicine and Infectious Diseases, Rm. A-421, 525 East 68th St., New York, NY 10065. Phone: (212) 746-6320. Fax: (212) 746-8675. E-mail: jlho{at}med.cornell.edu

{triangledown} Published ahead of print on 30 January 2008.

{ddagger} Supplemental material for this article may be found at http://jcm.asm.org/.

{dagger} A.L.G. and R.C.H. contributed equally to this study.


Journal of Clinical Microbiology, April 2008, p. 1259-1267, Vol. 46, No. 4
0095-1137/08/$08.00+0     doi:10.1128/JCM.02231-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2008 by the American Society for Microbiology. All rights reserved.